BackgroundCheck.run
Search For

Guo R ShiNew York, NY

Related to:
Kim Le Zhen Yu 54

Guo Shi Phones & Addresses

New York, NY   

8 Larrabee St, East Hartford, CT 06108    860-6108071   

30 Hillside St, East Hartford, CT 06108    860-2910422   

South Windsor, CT   

Get Report
Control this profile

Mentions for Guo R Shi

Guo Shi resumes & CV records

Resumes

Guo Shi Photo 19

Treasure

Location:
Elmhurst, NY
Industry:
Religious Institutions
Work:
Chan Meditation Center
Treasure Chan Meditation Center
Treasurer Chan Meditation Center
Nun
Languages:
Mandarin

Publications & IP owners

Us Patents

Compounds For The Treatment Of Dyslipidemia And Other Lipid Disorders

US Patent:
7629372, Dec 8, 2009
Filed:
Sep 12, 2005
Appl. No.:
11/662808
Inventors:
James F. Dropinski - Colts Neck NJ, US
Guo Q. Shi - Monmouth Junction NJ, US
Yong Zhang - West Windsor NJ, US
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 31/423
C07D 261/20
US Classification:
514379, 548240, 548241, 514378
Abstract:
A class of compounds having Formula I and pharmaceutically acceptable salts thereof are useful as therapeutic compounds, particularly in the treatment of hyperlipidemia, hypercholesterolemia, dyslipidemia, and other lipid disorders, and in delaying the onset of or reducing the risk of developing conditions and sequelae that are associated with these diseases, such as atherosclerosis.

Antidiabetic Oxazolidinediones And Thiazolidinediones

US Patent:
7807692, Oct 5, 2010
Filed:
Jun 30, 2006
Appl. No.:
11/922628
Inventors:
James F. Dropinski - Colts Neck NJ, US
Peter T. Meinke - Scotch Plains NJ, US
Guo Q. Shi - Monmouth Junction NJ, US
Yong Zhang - West Windsor NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/47
A61K 31/42
A61K 31/44
C07D 413/00
C07D 215/02
C07D 263/00
US Classification:
514307, 514314, 514376, 514340, 5462714, 546166, 548227
Abstract:
Phenoxyphenyl and phenoxybenzyl oxazolidine-2,4-diones and thiazolidine-2,4-diones are agonists or partial agonists of PPAR gamma and are useful in the treatment and control of hyperglycemia that is symptomatic of type II diabetes, as well as dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity that are often associated with type 2 diabetes.

Fused-Aromatic Compounds Having Anti-Diabetic Activity

US Patent:
7834036, Nov 16, 2010
Filed:
Mar 3, 2006
Appl. No.:
11/884802
Inventors:
Harold B. Wood - Westfield NJ, US
Peter T. Meinke - Scotch Plains NJ, US
Guo Q. Shi - Monmouth Junction NJ, US
Yong Zhang - West Windsor NJ, US
Assignee:
Merck Sharp & Dohme Corp - Rahway NJ
International Classification:
A61K 31/443
C07D 413/04
US Classification:
514338, 5462721
Abstract:
Fused aromatic compounds of Formula (I) are PPAR gamma agonists or partial agonists and are useful in the treatment or control of type II diabetes, including hyperglycemia, dyslipidermia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity that are often associated with type 2 diabetes.

Antidiabetic Oxazolidinediones And Thiazolidinediones

US Patent:
2009006, Mar 12, 2009
Filed:
Jul 14, 2006
Appl. No.:
11/988791
Inventors:
Peter T. Meinke - Scotch Plains NJ, US
Guo Q. Shi - Monmouth Junction NJ, US
Harold B. Wood - Westfield NJ, US
International Classification:
A61K 31/4439
C07D 417/12
US Classification:
514340, 5462714
Abstract:
Pyridinyloxyphenyl and pyridinyloxybenzyl oxazolidine-2,4-diones and thiazolidine-2,4-diones are agonists or partial agonists of PPAR gamma and are useful in the treatment and control of hyperglycemia that is symptomatic of type II diabetes, as well as dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity that are often associated with type 2 diabetes.

Possible Relatives

Debbie Shi  Danhong S Shi  Daniel Z Shi  Feng X Shi  Frank F Shi  Gary R Shi  Jeff B Shi  Guo Fan  Guo Jh 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.